A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

NCT01340937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2808

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Virus Diseases

Interventions

BIOLOGICAL: V419
BIOLOGICAL: PENTACEL™
BIOLOGICAL: Prevnar 13™
BIOLOGICAL: RotaTeq™
BIOLOGICAL: Recombivax HB vaccine

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]